Tetanus Immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. It should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. In all the above instances, active immunisation with Tetanus Toxoid, Adsorbed or ADT vaccine should be commenced at the same time [in accordance with details specified in table 1 (Guide to tetanus prophylaxis in wound management) in Indication section of the approved product information provided as Attachment 1]. Although Tetanus Immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.
How to take it
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Store at 2 to 8 degrees Celsius
Refrigerate
Protect from Light
Do not Freeze
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Colourless, clear to opalescent solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.